• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SISTEMAS MEDICOS ALARIS S.A. DE C.V. BD ALARIS PUMP MODULE SMARTSITE INFUSION SET; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SISTEMAS MEDICOS ALARIS S.A. DE C.V. BD ALARIS PUMP MODULE SMARTSITE INFUSION SET; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 2420-0007
Device Problem Material Separation (1562)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/23/2023
Event Type  malfunction  
Manufacturer Narrative
H3.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that bd alaris pump module smartsite infusion set separated.The following information was received by the initial reporter with the verbatim: product bd: product no.: lot no.: alaris lvp 20d 2ss cv iv pump infusion sets 2420-0007 (10) 23025193, (10) 23075292 secondary administration sets, non-vented needle-free valve, bag access port, roller clamp(s), texium closed male luer with hanger 10013364t (10) 23059177, (10) 23039137 manufacturer(s): bd.Problem: 1.The tubing in bd primary and secondary iv administration sets may separate from the drip chamber.Sets from the following lots have exhibited this problem: a.Primary sets product number 2420-0007, lot numbers: (10) 23025193, (10) 23075292.B.Secondary sets product number 10013364t, lot numbers: (10) 23059177, (10) 2303913.2.When this occurs: a.Medication may spill, potentially exposing staff and patients to toxic medication such as chemotherapy agents.B.Treatment may be delayed.
 
Manufacturer Narrative
It was reported by customer that the tubing in bd primary and secondary iv administration sets may separate from the drip chamber.Medication may spill.No product or photo was returned by the customer.The customer complaint of separation other component - leak could not be verified due to the product not being returned for failure investigation.Due to no sample being received, an investigation could not be performed and a root cause could not be determined.A device history record review for model 2420-0007, lot number 23025193 was performed.The search showed that a total of (b)(4) units in 1 lot number was built on 11feb2023.There were no quality notifications issued for the failure mode reported by the customer during the production build of this set.This incident has been added to our database of reported incidents.Our business team regularly reviews the collected data for identification of emerging trends.Your assistance in this matter has been helpful in trend identification and supporting our commitment to continuous quality improvement.H3 other text : see narrative below.
 
Event Description
No additional information for provided.Material #: 2420-0007, batch #: 23025193, 23075292.It was reported by customer that the tubing in bd primary and secondary iv administration sets may separate from the drip chamber.Medication may spill.Verbatim: product bd: product no.: lot no.: alaris lvp 20d 2ss cv iv pump infusion sets 2420-0007 (10) 23025193, (10) 23075292, secondary administration sets, non-vented needle-free valve, bag access port, roller, clamp(s), texium closed male luer with hanger, 10013364t (10) 23059177, (10) 23039137.Manufacturer(s): bd.Problem: 1.The tubing in bd primary and secondary iv administration sets may separate from the drip chamber.Sets from the following lots have exhibited this problem: a.Primary sets product number 2420-0007, lot numbers: (10) 23025193, (10) 23075292.B.Secondary sets product number 10013364t, lot numbers: (10) 23059177, (10) 2303913.2.When this occurs: a.Medication may spill, potentially exposing staff and patients to toxic medication such as chemotherapy agents.B.Treatment may be delayed.Response received 08 nov 2023.We did not have an issue with this.We were just inquiring about this.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD ALARIS PUMP MODULE SMARTSITE INFUSION SET
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
SISTEMAS MEDICOS ALARIS S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer (Section G)
SISTEMAS MEDICOS ALARIS, S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key18086484
MDR Text Key327611266
Report Number9616066-2023-02158
Device Sequence Number1
Product Code FPA
UDI-Device Identifier07613203021012
UDI-Public(01)07613203021012
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K221327
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/03/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number2420-0007
Device Lot Number23075292
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/23/2023
Initial Date FDA Received11/07/2023
Supplement Dates Manufacturer Received01/03/2024
Supplement Dates FDA Received01/12/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Type of Device Usage Initial
Patient Sequence Number1
-
-